IPP Bureau
Drager launches Atlan A100 anesthesia workstation in India
By IPP Bureau - April 12, 2025
The Atlan A100 system delivers advanced ventilation technology for adults, pediatric patients, and neonates, revolutionizing care with seamless workflows across hospital departments
FDA approves Opdivo plus Yervoy as treatment metastatic colorectal cancer
By IPP Bureau - April 12, 2025
The approval was granted more than two months ahead of the Prescription Drug User Fee Act goal date
Morepen to add 1,000 medical representatives
By IPP Bureau - April 12, 2025
The company is targeting a Rs. 1,000 crore finished dosages business within the next five years
.jpg "Cipla receives USFDA approval for Protein-bound Paclitaxel for Injectable Suspension")
Cipla receives USFDA approval for Protein-bound Paclitaxel for Injectable Suspension
By IPP Bureau - April 12, 2025
Protein-bound Paclitaxel is indicated for the treatment of metastatic breast cancer, locally advanced or metastatic non-small cell lung cancer and metastatic adenocarcinoma of the pancreas
Biocon Biologics announces USFDA approval for Jobevne biosimilar Bevacizumab
By IPP Bureau - April 11, 2025
Jobevne is a vascular endothelial growth factor (VEGF) inhibitor that binds with VEGF and blocks the interaction with its receptors to prevent angiogenesis
OneSource secures GMP approval from Brazil for its flagship facility in Bengaluru
By IPP Bureau - April 11, 2025
This approval marks a significant milestone in OneSource’s ongoing commitment to quality and regulatory compliance
US court lifts launch restrictions on Sun Pharma's autoimmune drug
By IPP Bureau - April 11, 2025
Sun Pharma has been involved in a patent infringement case with Incyte Corporation over LEQSELVI
Orchid Pharma to settle disputes with DBS Bank
By IPP Bureau - April 11, 2025
The company has entered into above Memo to settle, compromise and finally and forever resolve all disputes
Zeon Lifesciences appoints GK Sharma as Group Technical Director
By IPP Bureau - April 11, 2025
Sharma brings a wealth of expertise in optimizing manufacturing processes for fermentation-based APIs and sterile injectables
Granules India completes acquisition of Senn Chemicals
By IPP Bureau - April 11, 2025
Strengthening capabilities in Peptide Therapeutics and CDMO services
Sanofi India MD Rodolfo Hrosz to step down on April 30
By IPP Bureau - April 11, 2025
The board of directors accepted Hrosz’s resignation and expressed appreciation for his significant contributions during his tenure
Shilpa Medicare receives US approval for Varenicline Tablets, 0.5 mg and 1 mg
By IPP Bureau - April 10, 2025
Shilpa’s product has been approved as a generic version to the innovator - Chantix Tablets, 0.5 mg and 1 mg, of PF Prism C.V. (PF Prism)
AstraZeneca showcases innovation in infectious disease protection at ESCMID Global 2025
By IPP Bureau - April 10, 2025
Data highlight ambition to transform prevention and treatment for serious bacterial infections and develop novel preventative strategies for respiratory viral infections
Shilpa’s Unit-2 passes second consecutive FDA inspection with no 483s
By IPP Bureau - April 09, 2025
Raichur site is the group’s largest API facility and part of a wider network of seven sites
ZIM Laboratories and Globalpharma collaborate to commercialize oral thin film products in GCC
By IPP Bureau - April 09, 2025
This partnership encompasses dossier licensing, bulk product supply, and the licensing of ZIM Labs’ proprietary Oral Thin Film technology platform, ThinOral
